EGFR-mutant Non-small Cell Lung Cancer
4 clinical trials · Condition
◉ Watch EGFR-mutant Non-small Cell Lung Cancer
| Record | Firm | Date |
|---|---|---|
| Neoadjuvant Sacituzumab Tirumotecan and Limertinib for Potentially Resectable Stage Ⅲ EGFR-mutant Non-small Cell Lung Cancer (NCT07323056) | Shanghai Pulmonary Hospital, Shanghai, China | 2026-01-01 |
| A Study of VRN110755 in Patients With EGFR-Mutant Non-Small Cell Lung Cancer (NCT07699328) | Voronoi, Inc | 2024-03-26 |
| A Study of Famitinib in Combination With HS-10296 in Patients With EGFR-mutant NSCLC (NCT03904823) | Jiangsu HengRui Medicine Co., Ltd. | 2019-04-25 |
| Study of EGF816 in Combination With Selected Targeted Agents in EGFR-mutant NSCLC (NCT03333343) | Novartis Pharmaceuticals | 2018-01-29 |
Track EGFR-mutant Non-small Cell Lung Cancer automatically
Every clearance here is in the API, with alerts when new ones post.